A comparison of non-integrating reprogramming methods

Nature Biotechnology

Volumn 33, Issue 1, 2015, Pages 58-63

  Schlaeger, Thorsten M ^a,b   Daheron, Laurence ^b   Brickler, Thomas R ^b   Entwisle, Samuel ^b   Chan, Karrie ^a   Cianci, Amelia ^a   DeVine, Alexander ^a   Ettenger, Andrew ^a   Fitzgerald, Kelly ^a   Godfrey, Michelle ^a   Gupta, Dipti ^a   McPherson, Jade ^a   Malwadkar, Prerana ^a   Gupta, Manav ^a   Bell, Blair ^a   Doi, Akiko ^c,d   Jung, Namyoung ^c   Li, Xin ^c   Lynes, Maureen S ^b   Brookes, Emily ^a   Cherry, Anne B C ^a,e   Demirbas, Didem ^a   Tsankov, Alexander M ^b,f   Zon, Leonard I ^a,b   Rubin, Lee L ^b,g   Feinberg, Andrew P ^c   Meissner, Alexander ^b,f   Cowan, Chad A ^b,f,g,h   Daley, George Q ^a,b,e   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^g Harvard University   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY;

ANEUPLOIDY; CLINICAL TRANSLATION; DISEASE MODELING; DRUG DISCOVERY; HIGH QUALITY; HUMAN-INDUCED PLURIPOTENT STEM CELLS; MRNA TRANSFECTION; SYSTEMATIC EVALUATION;

STEM CELLS;

GENOMIC DNA; MESSENGER RNA;

ANEUPLOIDY; ARTICLE; CELL COUNT; CLUSTER ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; COPY NUMBER VARIATION; DNA METHYLATION; EPISOMAL TRANSFECTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PLURIPOTENT STEM CELL; LENTIVIRAL PLASMID; MRNA TRANSFECTION; NUCLEAR REPROGRAMMING; PLASMID; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RELIABILITY; SENDAI VIRUS TRANSFECTION; CYTOLOGY;

CELLULAR REPROGRAMMING; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84925341709     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3070     Document Type: Article

References (40)

1. Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861-872 (2007).
2. Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 (2007).
3. Park, I.H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141-146 (2008).
4. Fusaki, N. et al. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn. Acad., Ser. B, Phys. Biol. Sci. 85, 348-362 (2009).
5. Okita, K. et al. A more efficient method to generate integration-free human iPS cells. Nat. Methods 8, 409-412 (2011).
6. Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2010).
7. Yu, J. et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324, 797-801 (2009).
8. Goh, P.A. et al. A systematic evaluation of integration free reprogramming methods for deriving clinically relevant patient specific induced pluripotent stem (iPS) cells. PLoS ONE 8, e81622 (2013).
9. Lieu, P.T. et al. Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus. Methods Mol. Biol. 997, 45-56 (2013).
10. Warren, L., Ni, Y., Wang, J. & Guo, X. Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Sci. Rep. 2, 657 (2012).
11. Somers, A. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28, 1728-1740 (2010).
12. Gore, A. et al. Somatic coding mutations in human induced pluripotent stem cells. Nature 471, 63-67 (2011).
13. Laurent, L.C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 (2011).
14. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).
15. Ruiz, S. et al. Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. Proc. Natl. Acad. Sci. USA 109, 16196-16201 (2012).
16. Carey, B.W. et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9, 588-598 (2011).
17. Koyanagi-Aoi, M. et al. Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells. Proc. Natl. Acad. Sci. USA 110, 20569-20574 (2013).
18. Bock, C. et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
19. Buganim, Y. et al. The developmental potential of iPSCs is greatly influenced by reprogramming factor selection. Cell Stem Cell 15, 295-309 (2014).
20. Park, T.S. et al. Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate non-integrated iPSC reprogramming of human myeloid progenitors. PLoS ONE 7, e42838 (2012).
21. Okita, K. et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells 31, 458-466 (2013).
22. Yu, J., Chau, K.F., Vodyanik, M.A., Jiang, J. & Jiang, Y. Efficient feeder-free episomal reprogramming with small molecules. PLoS ONE 6, e17557 (2011).
23. Chen, G. et al. Chemically defined conditions for human iPSC derivation and culture. Nat. Methods 8, 424-429 (2011).
24. Su, R.J. et al. Efficient generation of integration-free ips cells from human adult peripheral blood using BCL-XL together with Yamanaka factors. PLoS ONE 8, e64496 (2013).
25. Wang, Y. et al. Reprogramming of mouse and human somatic cells by high-performance engineered factors. EMBO Rep. 12, 373-378 (2011).
26. MacArthur, C.C. et al. Generation of human-induced pluripotent stem cells by a nonintegrating RNA Sendai virus vector in feeder-free or xeno-free conditions. Stem Cells Int. 2012, 564612 (2012).
27. Awe, J.P. et al. Generation and characterization of transgene-free human induced pluripotent stem cells and conversion to putative clinical-grade status. Stem Cell Res. Ther. 4, 87 (2013).
28. Nakagawa, M. et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci. Rep. 4, 3594 (2014).
29. Hou, P. et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science 341, 651-654 (2013).
30. Jiang, J. et al. Zscan4 promotes genomic stability during reprogramming and dramatically improves the quality of iPS cells as demonstrated by tetraploid complementation. Cell Res. 23, 92-106 (2013).
31. Hartung, O., Huo, H., Daley, G.Q. & Schlaeger, T.M. Clump passaging and expansion of human embryonic and induced pluripotent stem cells on mouse embryonic fibroblast feeder cells. Curr. Protoc. Stem Cell Biol. 14, 1C.10 (2010).
32. Manos, P.D., Ratanasirintrawoot, S., Loewer, S., Daley, G.Q. & Schlaeger, T.M. Live-cell immunofluorescence staining of human pluripotent stem cells. Curr. Protoc. Stem Cell Biol. 19, 1C.12 (2011).
33. Somers, A. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28, 1728-1740 (2010).
34. Park, I.H., Lerou, P.H., Zhao, R., Huo, H. & Daley, G.Q. Generation of human-induced pluripotent stem cells. Nat. Protoc. 3, 1180-1186 (2008).
35. Miller, J.D. & Schlaeger, T.M. Generation of induced pluripotent stem cell lines from human fibroblasts via retroviral gene transfer. Methods Mol. Biol. 767, 55-65 (2011).
36. Chan, E.M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nat. Biotechnol. 27, 1033-1037 (2009).
37. Bock, C. et al. Reference Maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439-452 (2011).
38. Hansen, K.D. et al. From whole genome bisulfite sequencing reads to differentially methylated regions. Genome Biol. 13, R83 (2012).
39. Hansen, K.D. et al. Increased methylation variation in epigenetic domains across cancer types. Nat. Genet. 43, 768-775 (2011).
40. Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68-73 (2011).